The global needle free injection market size was valued at USD 125 million in 2021 and is poised to grow at a significant CAGR of 17.2% during the forecast period 2022-28. Needle-free injection (NFI) is a comparatively recent technology that uses a small, precise fluid stream to deliver medications or vaccinations intramuscularly or subcutaneously. Self-administration of pharmaceuticals and the removal of needle fear are two advantages of the needle-free injection technique. The term "needle-free injection systems" refers to a variety of medication delivery devices that do not require the use of needles. It is feasible to inject highly viscous drugs that cannot be administered with ordinary syringe devices.

View Detailed Report Description at https://precisionbusinessinsights.com/market-reports/global-needle-free-injection-market/        

Chronic diseases, as well as lifestyle disorders, are becoming more common around the world. Several chronic diseases have become more common in the previous decade, necessitating lengthy hospital stays in some situations. Cancer, renal failure, and heart disease are only a few of the main chronic diseases. Hypertension, diabetes, cholesterol, & overweight/obesity are just a few of the lifestyle disorders that are becoming substantial risk factors.  

The global needle free injection market segmentation:
1) By Product: Fillable and Prefilled
2) Source of Power: Spring-based Injector Systems and Gas Propelled/Air Forced Injector Systems.
3) By Type: Liquid-based, Projectile/Depot-based, and Powder-based
4) Site of Delivery: Subcutaneous Injectors, Intramuscular Injectors, and Intradermal Injectors.
5) Application: Vaccine Delivery, Insulin Delivery, and Pain Management
6) End User: Hospitals & Clinics, Home Care Settings, and Research Laboratories

The needle free injection market research report gives a comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Due to increased R&D spending, North America dominates the needle-free injection systems market, whereas Europe is expected to grow at the highest rate from 2022 to 2029 owing to increase demand for biologics, increasing incidence of chronic diseases, technological developments, acquisitions and mergers by key market players, favorable government initiatives, cost of medical care, and regulatory standards.

Request sample report at  https://precisionbusinessinsights.com/request-sample?product_id=36215                                                                        

The needle free injection market key players are Antares Pharma, , (U.S.) Crossject needle-free injection systems ( France) D’Antonio Consultants International Inc. (U.S.) European Pharma Group (Netherlands) Endo Pharmaceuticals Inc. (Ireland) INJEX Pharma GmBH. (Germany) Medical International Technology, Inc., (Canada) National Medical Products Inc., (Saudi Arabia) Mika Medical Co., (Korea) PenJet Corporation. (U.S.)

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers 

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll-Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747